cup-2 Antibody
Description
Introduction to CUP-2 Antibody
CUP-2 (coelomocyte uptake defective) is a protein first identified in Caenorhabditis elegans (C. elegans) as essential for endocytosis in coelomocytes, scavenger-like cells responsible for cellular uptake and degradation . Antibodies targeting CUP-2 are critical tools for studying its role in endoplasmic reticulum-associated degradation (ERAD), endocytosis, and its implications in developmental biology and cancer.
Biological Role of CUP-2
CUP-2 functions as a Derlin family protein, homologous to human Derlin-2 and Derlin-3, and plays dual roles in:
-
ERAD: Mediating the retrotranslocation of misfolded proteins from the ER to the cytosol for proteasomal degradation .
-
Endocytosis: Faculating the uptake of plasma membrane proteins via interactions with SNX-1 (sorting nexin), a component of the retromer complex .
Loss of CUP-2 activity leads to ER stress, activation of the unfolded protein response (UPR), and impaired degradation of Notch signaling components .
Key Interactions and Pathways
-
SNX-1 Binding: CUP-2 collaborates with SNX-1 to recognize misfolded plasma membrane proteins, directing them to the ER for degradation .
-
Notch Signaling Regulation: In C. elegans, CUP-2 modulates GLP-1/Notch signaling by controlling the turnover of Notch receptors. Suppression of cup-2 reduces germline tumor overproliferation in puf-8(0); glp-1(gf) mutants .
Tumor Suppression in C. elegans
Studies show that cup-2 loss-of-function suppresses Notch-dependent tumorigenesis:
| Genotype | Tumor Incidence (Incomplete Tumors) | Wild-Type Phenotype (%) |
|---|---|---|
| rfp-1(ok572); glp-1(oz264gf) | 61% | 39% |
| cup-2(0); rfp-1; glp-1(gf) | 7% | 93% |
Data adapted from suppression experiments in C. elegans germline tumors .
-
ER Stress Correlation: cup-2 mutants exhibit elevated HSP-4::GFP (a UPR marker), confirming ER stress as a driver of tumor suppression .
Applications in Research
CUP-2 antibodies are pivotal for:
-
ERAD Pathway Analysis: Identifying substrates and regulatory mechanisms in protein quality control.
-
Cancer Models: Investigating links between ER stress, Notch signaling, and tumorigenesis.
-
Drug Discovery: Targeting Derlin homologs in human cancers showing ERAD dysregulation.
Future Directions
Current research focuses on:
-
Elucidating CUP-2’s role in cross-species ERAD conservation.
-
Developing therapeutic strategies that exploit ER stress pathways in Notch-driven cancers.
